These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 28067167)
21. In vitro study of interaction of 17β-hydroxysteroid dehydrogenase type 10 and cyclophilin D and its potential implications for Alzheimer's disease. Hemmerová E; Špringer T; Krištofiková Z; Homola J Sci Rep; 2019 Nov; 9(1):16700. PubMed ID: 31723183 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease. Yao J; Du H; Yan S; Fang F; Wang C; Lue LF; Guo L; Chen D; Stern DM; Gunn Moore FJ; Xi Chen J; Arancio O; Yan SS J Neurosci; 2011 Feb; 31(6):2313-20. PubMed ID: 21307267 [TBL] [Abstract][Full Text] [Related]
24. Study of Biomolecular Interactions of Mitochondrial Proteins Related to Alzheimer's Disease: Toward Multi-Interaction Biomolecular Processes. Hemmerová E; Špringer T; Krištofiková Z; Homola J Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32825572 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol. Lim YA; Grimm A; Giese M; Mensah-Nyagan AG; Villafranca JE; Ittner LM; Eckert A; Götz J PLoS One; 2011; 6(12):e28887. PubMed ID: 22174920 [TBL] [Abstract][Full Text] [Related]
26. Morphology-Specific Inhibition of β-Amyloid Aggregates by 17β-Hydroxysteroid Dehydrogenase Type 10. Aitken L; Quinn SD; Perez-Gonzalez C; Samuel ID; Penedo JC; Gunn-Moore FJ Chembiochem; 2016 Jun; 17(11):1029-37. PubMed ID: 26991863 [TBL] [Abstract][Full Text] [Related]
27. Identification of small-molecule inhibitors of the Abeta-ABAD interaction. Xie Y; Deng S; Chen Z; Yan S; Landry DW Bioorg Med Chem Lett; 2006 Sep; 16(17):4657-60. PubMed ID: 16781151 [TBL] [Abstract][Full Text] [Related]
28. Effects of novel 17β-hydroxysteroid dehydrogenase type 10 inhibitors on mitochondrial respiration. Fišar Z; Musílek K; Benek O; Hroch L; Vinklářová L; Schmidt M; Hroudová J; Raboch J Toxicol Lett; 2021 Mar; 339():12-19. PubMed ID: 33359020 [TBL] [Abstract][Full Text] [Related]
29. (-)-CHANA, a fluorogenic probe for detecting amyloid binding alcohol dehydrogenase HSD10 activity in living cells. Muirhead KE; Froemming M; Li X; Musilek K; Conway SJ; Sames D; Gunn-Moore FJ ACS Chem Biol; 2010 Dec; 5(12):1105-14. PubMed ID: 20836522 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitors: Selectivity, metabolic stability and enhanced potency. Boutin S; Maltais R; Roy J; Poirier D Eur J Med Chem; 2021 Jan; 209():112909. PubMed ID: 33081987 [TBL] [Abstract][Full Text] [Related]
31. Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease. Morsy A; Trippier PC J Med Chem; 2019 May; 62(9):4252-4264. PubMed ID: 30444369 [TBL] [Abstract][Full Text] [Related]
32. Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model. Zakaria A; Hamdi N; Abdel-Kader RM Mol Neurobiol; 2016 Mar; 53(2):1220-1228. PubMed ID: 25601181 [TBL] [Abstract][Full Text] [Related]
33. ABAD/17β-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP/PS1 mice. Xiao X; Chen Q; Zhu X; Wang Y Neurobiol Aging; 2019 Sep; 81():77-87. PubMed ID: 31252207 [TBL] [Abstract][Full Text] [Related]
35. Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction. Valaasani KR; Sun Q; Hu G; Li J; Du F; Guo Y; Carlson EA; Gan X; Yan SS Curr Alzheimer Res; 2014 Feb; 11(2):128-36. PubMed ID: 24479630 [TBL] [Abstract][Full Text] [Related]
36. Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD). Powell AJ; Read JA; Banfield MJ; Gunn-Moore F; Yan SD; Lustbader J; Stern AR; Stern DM; Brady RL J Mol Biol; 2000 Oct; 303(2):311-27. PubMed ID: 11023795 [TBL] [Abstract][Full Text] [Related]
38. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease. Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718 [TBL] [Abstract][Full Text] [Related]
39. Levels of 17β-hydroxysteroid dehydrogenase type 10 in CSF are not a valuable biomarker for multiple sclerosis. Kristofikova Z; Ricny J; Kaping D; Klaschka J; Kotoucova J; Bartos A Biomark Med; 2018 Dec; 12(12):1331-1340. PubMed ID: 30520659 [TBL] [Abstract][Full Text] [Related]
40. Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease. Valasani KR; Hu G; Chaney MO; Yan SS Chem Biol Drug Des; 2013 Feb; 81(2):238-49. PubMed ID: 23039767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]